Puma Biotechnology, Inc. (PBYI) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q3 26	$0.07	$0.2	+185.7%	—	—	—
Q2 26	-$0.13	-$0.04	+69.2%	—	—	—
Q1 26	$0.23	$0.29	+26.1%	—	—	—
Q4 25	$0.09	$0.21	+133.3%	—	—	—
Q3 25	$0.07	$0.15	+114.3%	—	—	—
Q2 25	-$0.02	$0.06	+400.0%	—	—	—
Q1 25	$0.14	$0.43	+207.1%	—	—	—
Q4 24	$0.38	$0.45	+18.4%	—	—	—
Q3 24	-$0.1	-$0.05	+50.0%	—	—	—
Q2 24	-$0.15	-$0.05	+66.7%	—	—	—
Q1 24	$0.37	$0.31	-16.2%	—	—	—
Q4 23	$0.08	$0.12	+50.0%	—	—	—
Q3 23	$0.01	$0.05	+400.0%	—	—	—
Q2 23	-$0.07	$0.03	+142.9%	—	—	—
Q1 23	—	-$0.12	—	—	—	—
Q4 22	-$0.05	-$0.01	+80.0%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.62	—	—	$228.4M	—
FY24	—	$0.62	—	—	$230.5M	—
FY23	—	$0.46	—	—	$235.6M	—
FY22	—	$0	—	—	$228M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$0	$27.7M	$251M	$272.3M	$225.1M	$253.2M	$228M	$235.6M	$230.5M	$228.4M
YoY change	0%	+InfinityT%	+806.6%	+8.47%	-17.3%	+12.5%	-9.92%	+3.34%	-2.19%	-0.91%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	0	27.7M	251M	272.3M	225.1M	253.2M	228M	235.6M	230.5M	228.4M
Cost of revenue	0	5.6M	34.6M	36.8M	39.4M	63.7M	55.1M	62.7M	64.4M	58.2M
Gross profit	0	22.1M	216.4M	235.4M	185.7M	189.5M	172.9M	173M	166.1M	170.2M
Gross margin	—	79.9%	86.2%	86.5%	82.5%	74.8%	75.8%	73.4%	72.1%	74.5%
Research & development	222.8M	207.8M	164.9M	132.9M	97.7M	71.9M	52.2M	50.4M	54.9M	62.1M
Selling, general & administrative	53.8M	106.7M	146.2M	141.6M	118.5M	116.3M	90M	88.4M	80.7M	71.2M
Operating expenses	276.6M	314.5M	311M	274.5M	216.1M	188.2M	142.2M	138.8M	135.6M	133.3M
Operating income	-276.6M	-292.4M	-94.7M	-39M	-30.4M	1.3M	30.7M	33.3M	31M	37.3M
Operating margin	—	-1.1K%	-37.7%	-14.3%	-13.5%	0.51%	13.5%	14.1%	13.4%	16.3%
Non-operating income, net	-373K	-101K	-9.7M	-24.3M	-15.8M	-17.4M	-19.5M	134K	862K	1M
Pretax income	-276M	-292M	-113.6M	-75.5M	-59.8M	-28.8M	457K	22.7M	24.1M	35.8M
Income tax	—	—	17K	53K	207K	324K	455K	1.1M	-6.2M	4.7M
Net income	-276M	-292M	-113.6M	-75.6M	-60M	-29.1M	2K	21.6M	30.3M	31.1M
Net margin	—	-1.1K%	-45.3%	-27.8%	-26.7%	-11.5%	0%	9.16%	13.1%	13.6%
EBITDA	-274.9M	-288.4M	-86.2M	-28M	-19.5M	13M	41.3M	48.1M	48.1M	53.3M
EPS	-8.29	-7.85	-2.99	-1.95	-1.52	-0.72	0	0.46	0.62	0.62
Diluted EPS	-8.29	-7.85	-2.99	-1.95	-1.52	-0.72	0	0.45	0.62	0.61

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	56.1M	72.2M	43.8M	47.1M	80.5M	59.1M	46M	52.4M	54.5M	75.5M	44.8M	56.5M
Cost of revenue	13.3M	24.3M	10.7M	10.7M	29.1M	13.9M	10.6M	12.3M	12.2M	23.1M	10.4M	12.5M
Gross profit	42.8M	47.9M	33M	36.4M	51.4M	45.2M	35.5M	40.1M	42.3M	52.3M	34.4M	44M
Gross margin	76.3%	66.3%	75.5%	77.4%	63.9%	76.4%	77.1%	76.5%	77.7%	69.3%	76.7%	77.9%
Research & development	11.4M	12.9M	13.6M	13.6M	12.5M	15.2M	13.9M	15.5M	15.9M	16.8M	19.8M	18.9M
Selling, general & administrative	22.2M	19.8M	21.6M	25.2M	16.9M	17M	17.4M	18.4M	17M	18.4M	18.4M	17.5M
Operating expenses	33.6M	32.7M	35.2M	38.8M	29.4M	32.2M	31.3M	33.9M	32.9M	35.2M	38.2M	36.4M
Operating income	9.2M	14.8M	-2.3M	-2.2M	22.1M	13.4M	4M	6.6M	9.6M	17.1M	-3.8M	7.6M
Operating margin	16.4%	20.5%	-5.25%	-4.63%	27.4%	22.6%	8.66%	12.7%	17.6%	22.7%	-8.54%	13.4%
Non-operating income, net	-551K	641K	91K	156K	347K	268K	359K	410K	115K	143K	130K	9K
Pretax income	6M	12.8M	-4.6M	-4.2M	20.6M	12.2M	3.3M	6.2M	9.2M	17.1M	-3.4M	8.2M
Income tax	213K	536K	220K	378K	291K	-7.1M	293K	310K	399K	3.7M	326K	56K
Net income	5.8M	12.3M	-4.8M	-4.5M	20.3M	19.3M	3M	5.9M	8.8M	13.4M	-3.8M	8.2M
Net margin	10.3%	17%	-11%	-9.62%	25.2%	32.7%	6.46%	11.2%	16.2%	17.8%	-8.37%	14.5%
EBITDA	12.8M	19M	1.7M	2.1M	26.6M	17.7M	8.2M	10.8M	13.5M	20.9M	-112K	10.9M
EPS	0.12	—	-0.1	-0.09	0.41	0.39	0.06	0.12	0.18	0.27	-0.07	0.16
Diluted EPS	0.12	—	-0.1	-0.09	0.41	0.39	0.06	0.12	0.17	0.26	-0.07	0.16

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	1B	—	772.1M	339.2M	406.1M	123.5M	189M	204.1M	148.4M	297.6M	506.9M
Enterprise value	792.7M	—	758.6M	347.8M	433.6M	158.1M	222.2M	219.6M	121.5M	228.6M	415.2M
Shares outstanding	33.3M	37.2M	37.9M	38.8M	39.6M	40.6M	44.7M	47.1M	48.6M	50M	50M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	—	—	94.5K	9.45	4.9	9.56	19.1
P/S	—	—	3.08	1.25	1.8	0.49	0.83	0.87	0.64	1.3	2.18
P/B	4.87	—	22.5	19.4	-68.2	-50.5	8.75	3.82	1.61	2.28	3.59
EV/EBITDA	-2.88	—	-8.8	-12.4	-22.2	12.1	5.37	4.56	2.53	4.29	10.4
EV/Sales	—	—	3.02	1.28	1.93	0.62	0.97	0.93	0.53	1	1.8
Earnings yield	—	—	—	—	—	—	0%	10.6%	20.4%	10.5%	5.23%
FCF yield	-14.6%	—	-3.2%	6.51%	-2.28%	16.7%	-12.1%	7.04%	26.2%	14%	6.41%
PEG	—	—	—	—	—	—	—	—	—	—	0.57

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	—	79.9%	86.2%	86.5%	82.5%	74.8%	75.8%	73.4%	72.1%	74.5%	77.9%
Operating margin	—	-1.1K%	-37.7%	-14.3%	-13.5%	0.51%	13.5%	14.1%	13.4%	16.3%	13.4%
Net margin	—	-1.1K%	-45.3%	-27.8%	-26.7%	-11.5%	0%	9.16%	13.1%	13.6%	11.6%
ROE	-131.5%	-547.7%	-331.1%	-432.9%	1K%	1.2K%	0.01%	40.4%	32.9%	23.9%	22%
ROA	-109.2%	-176.4%	-43.8%	-32.2%	-24.6%	-12.9%	0%	9.37%	14.2%	14.4%	9.81%
ROIC	—	—	-455.7%	-149.9%	-140.7%	4.02%	0.25%	45.9%	47.5%	52.9%	52.8%
Return on tangible assets	-109.2%	-424.3%	-66.7%	-49.1%	-62.5%	-30.9%	0%	19.8%	27.3%	23.3%	22.3%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	6.31	1.82	3.02	1.83	1.28	1.28	1.73	1.57	1.54	2	2.91
Quick ratio	6.31	1.79	2.99	1.8	1.25	1.21	1.67	1.5	1.45	1.93	2.64
Debt / equity	—	0.91	4.43	6.88	-20.3	-47.7	5.29	2.09	0.8	0.22	0.03
Debt / assets	—	0.29	0.59	0.51	0.5	0.51	0.51	0.48	0.35	0.13	0.02
Net debt / EBITDA	—	0.12	0.16	-0.31	-1.41	2.65	0.8	0.32	-0.56	-1.29	-1.97
Interest coverage	—	-404.5	-9.34	-4.03	-3.26	-1.25	1.04	2.7	2.94	6.4	9.86
Effective tax rate	—	—	0%	0%	0%	0%	99.6%	4.78%	0%	13.1%	14.3%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	0	0.74	6.62	7.02	5.69	6.23	5.1	5	4.74	4.57	4.57
EPS (basic)	-8.29	-7.85	-2.99	-1.95	-1.52	-0.72	0	0.46	0.62	0.62	0.62
EPS (diluted)	-8.29	-7.85	-2.99	-1.95	-1.52	-0.72	0	0.45	0.62	0.61	0.51
Book value per share	6.3	1.43	0.9	0.45	-0.15	-0.06	0.48	1.13	1.89	2.61	2.71
FCF per share	-4.47	-6	-0.65	0.57	-0.23	0.51	-0.51	0.3	0.8	0.83	0.78
Cash per share	6.89	2.2	4.36	2.88	2.36	2.02	1.81	2.04	2.08	1.95	1.82
Capex per share	0.22	0.01	0.02	0.01	0	0	0	0	0	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	1.56%	0.24%	0.11%	0.02%	0%	0%	0.06%	0.02%	—	—
Capex / operating cash flow	-4.82%	-0.23%	-1.55%	-3.04%	-0.21%	0%	0%	0.43%	0.1%	—	—
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$56.1M	$72.2M	$43.8M	$47.1M	$80.5M	$59.1M	$46M	$52.4M	$54.5M	$75.5M	$44.8M	$56.5M
YoY change	-1.73%	+9.9%	-17.1%	-13.7%	+43.5%	-18.2%	+5.12%	+11.4%	-32.4%	+27.7%	-2.59%	+7.75%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	229.5M	81.7M	165.4M	111.6M	93.4M	82.1M	81.1M	95.9M	101M	97.5M
Receivables	0	9.7M	20.8M	28.9M	25.5M	32.5M	40.4M	47.8M	32M	53.7M
Inventory	0	2M	2.6M	3.2M	3.5M	7.1M	4.5M	7.1M	8.7M	5.5M
Total current assets	236.5M	106.4M	203M	166.3M	146.1M	140M	134.3M	156.2M	147.7M	162.7M
Property, plant & equipment	5.2M	4.5M	4M	21.8M	18.9M	15.8M	1.1M	855K	610K	187K
Goodwill & intangibles	0	96.7M	88.8M	80.9M	148.3M	132.3M	141.2M	121.7M	102.3M	82.8M
Total assets	252.8M	165.5M	259.1M	234.9M	244.2M	226.6M	222.1M	230.5M	213.3M	216.3M
Accounts payable	20M	27.7M	20.7M	19.2M	12.1M	11.2M	6.4M	6.9M	5.5M	5.1M
Short-term debt	—	—	—	2.6M	17.4M	3.6M	4.1M	38.8M	50.9M	23.8M
Total current liabilities	37.5M	58.3M	67.1M	90.8M	114.3M	109.6M	77.5M	99.4M	96.1M	81.3M
Long-term debt	—	48.5M	151.9M	117.6M	103.6M	113.1M	110.1M	72.7M	23.2M	4.7M
Total liabilities	43M	112.2M	224.8M	217.4M	250.2M	229M	200.5M	177.1M	121.2M	86M
Shareholders' equity	209.8M	53.3M	34.3M	17.5M	-6M	-2.4M	21.6M	53.4M	92.1M	130.3M
Total debt	—	48.5M	151.9M	120.2M	121M	116.6M	114.3M	111.5M	74.1M	28.5M
Net debt	—	-33.2M	43.5M	60.2M	35.7M	53.5M	38.1M	26.9M	4.9M	-1.1M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	85M	95.9M	107.2M	96.8M	96.7M	101M	93.2M	96M	94.4M	97.5M	101.5M	93.9M
Receivables	29M	47.8M	24.6M	28.1M	54.6M	32M	25.2M	25.9M	33.6M	53.7M	26.3M	34.1M
Inventory	5.7M	7.1M	7.1M	9M	2.7M	8.7M	8.8M	8.6M	9.5M	5.5M	8.7M	13.3M
Total current assets	125.4M	156.2M	143M	137.7M	156.8M	147.7M	132.5M	136.6M	143.6M	162.7M	142.3M	145.1M
Property, plant & equipment	9.4M	855K	7.8M	6.9M	6M	610K	4.2M	388K	305K	187K	124K	103K
Goodwill & intangibles	126.6M	121.7M	116.9M	112M	107.1M	102.3M	97.4M	92.5M	87.7M	82.8M	77.9M	73M
Total assets	203.6M	230.5M	214.1M	205M	220.7M	213.3M	196.2M	194.9M	202.9M	216.3M	192.7M	192.7M
Accounts payable	5.1M	6.9M	9M	13.5M	7.5M	5.5M	6M	5.4M	6.4M	5.1M	8.2M	3.1M
Short-term debt	27.3M	38.8M	50.3M	50.5M	50.7M	50.9M	51.1M	38.4M	36.2M	23.8M	11.4M	450K
Total current liabilities	67.4M	99.4M	98.2M	104.3M	110.4M	96.1M	86.7M	79.1M	82.7M	81.3M	59.7M	49.8M
Long-term debt	84.9M	72.7M	60.4M	48.1M	35.7M	23.2M	10.6M	10.9M	4.9M	4.7M	4.5M	4.4M
Total liabilities	164.9M	177.1M	163.2M	156.5M	149.6M	121.2M	99.1M	90.2M	87.6M	86M	64.3M	54.2M
Shareholders' equity	38.7M	53.4M	51M	48.5M	71.1M	92.1M	97.1M	104.7M	115.3M	130.3M	128.4M	138.5M
Total debt	112.2M	111.5M	110.7M	98.6M	86.4M	74.1M	61.7M	49.2M	41.1M	28.5M	16M	4.8M
Net debt	30.4M	26.9M	34M	31.4M	19.1M	4.9M	-1.3M	-5.4M	-12.5M	-1.1M	-20.2M	-31.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	-276M	-292M	-113.6M	-75.6M	-60M	-29.1M	2K	21.6M	30.3M	31.1M
Depreciation & amortization	1.1M	2.8M	7.4M	8.1M	10M	11.3M	9.8M	11.5M	11.5M	10.9M
Stock-based compensation	117.3M	108.7M	86.9M	57.3M	36.6M	32.6M	11.8M	10.2M	8.2M	6.9M
Change in working capital	6.3M	-4.1M	-20.1M	116K	-8.3M	-9.2M	-13.8M	-11.1M	4.2M	-22.9M
Operating cash flow	-151.3M	-184.6M	-39.3M	-10.1M	-21.7M	5.6M	14.9M	32.3M	54.3M	41.8M
Capital expenditure	-7.3M	-431K	-609K	-306K	-46K	0	0	-140K	-56K	—
Investing cash flow	142.2M	34.6M	-57.6M	5.2M	43.4M	-10.9M	14.1M	-6.6M	-20.4M	-36.1M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—
Financing cash flow	161.9M	48.4M	100.8M	-68.4M	-10M	-31.9M	12.2M	0	-34M	-45.3M
Net change in cash	152.8M	-101.6M	3.8M	-73.3M	11.7M	-37.2M	41.2M	25.6M	-174K	-39.6M
Free cash flow	-149M	-222.9M	-24.7M	22.1M	-9.3M	20.6M	-22.8M	14.4M	38.9M	41.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	5.8M	12.3M	-4.8M	-4.5M	20.3M	19.3M	3M	5.9M	8.8M	13.4M	-3.8M	8.2M
Depreciation & amortization	2.9M	2.9M	2.9M	2.9M	2.9M	2.8M	2.8M	2.8M	2.7M	2.7M	2.6M	2.5M
Stock-based compensation	2.5M	2.4M	2.4M	2.1M	2.1M	1.8M	2M	1.6M	1.7M	1.6M	1.9M	2M
Change in working capital	-423K	-18.3M	25.3M	-1.5M	-26.8M	7.3M	6.3M	-2M	-8.5M	-18.7M	26.3M	-17.7M
Operating cash flow	10.8M	-683K	25.7M	-1M	-1.6M	31.2M	14.1M	14.1M	9.7M	14.4M	15.4M	1.6M
Capital expenditure	-27K	-45K	—	-20K	-20K	-16K	-61K	—	—	—	—	—
Investing cash flow	11.2M	-8.2M	-19.1M	703K	259K	-2.3M	1.5M	-11.2M	532K	-27M	2.5M	8M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	0	0	—	-11.1M	-11.3M	-11.3M	-11.3M	-11.3M	-11.3M	-11.3M	-11.3M	-11.3M
Net change in cash	22M	-8.9M	6.7M	-11.5M	-12.6M	17.5M	4.3M	-8.5M	-1.1M	-23.9M	6.6M	-1.7M
Free cash flow	10.6M	10.4M	11.2M	1M	11M	15.6M	3.6M	14.1M	9.7M	14.5M	15.4M	1.6M

Puma Biotechnology, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement